Influenza A virus H5N1 vaccine - Denka Seiken

Drug Profile

Influenza A virus H5N1 vaccine - Denka Seiken

Alternative Names: A-04-01D

Latest Information Update: 25 Nov 2015

Price : $50

At a glance

  • Originator Denka Seiken
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza A virus H5N1 subtype

Most Recent Events

  • 25 Nov 2015 No recent reports on development identified - Phase-II/III for Influenza-A virus H5N1 subtype (Prevention, In adults) in Japan (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top